We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
124 hedge funds and large institutions have $1.7B invested in Atara Biotherapeutics in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 60 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
107% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 29
100% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 10
20% more call options, than puts
Call options by funds: $14.4M | Put options by funds: $12M
9% more funds holding
Funds holding: 114 → 124 (+10)
0% more capital invested
Capital invested by funds: $1.7B → $1.7B (+$5.06M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.27% less ownership
Funds ownership: 4.49% → 4.23% (-0.27%)
Holders
124
Holders Change
+10
Holders Change %
+8.77%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
60
Reduced
29
Closed
10
Calls
$14.4M
Puts
$12M
Net Calls
+$2.39M
Net Calls Change
-$24.2M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$37.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.4M |
| 3 |
BlackRock
New York
|
+$22.4M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$14.3M |
| 5 |
Goldman Sachs
New York
|
+$10.7M |
Top Sellers
| 1 |
PC
PointState Capital
New York
|
-$11.6M |
| 2 |
AG
Artal Group
Luxembourg
|
-$10.7M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$7.69M |
| 4 |
Jennison Associates
New York
|
-$7.05M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.09M |
